Purple Biotech Ltd
PPBT
$2.42
-$0.0363-1.48%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | 196.00K | 196.00K | 196.00K | |
| Gross Profit | -- | -196.00K | -196.00K | -196.00K | |
| SG&A Expenses | -- | 3.90M | 4.46M | 5.04M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 19.74M | 21.62M | 22.27M | |
| Operating Income | -- | -19.74M | -21.62M | -22.27M | |
| Income Before Tax | -- | -16.11M | -18.86M | -19.98M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -16.11 | -18.86 | -19.98 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | 79.00K | 91.00K | 97.00K | |
| Net Income | -- | -16.03M | -18.76M | -19.88M | |
| EBIT | -- | -19.74M | -21.62M | -22.27M | |
| EBITDA | -- | -19.58M | -21.45M | -22.11M | |
| EPS Basic | -- | -2.83 | -2.84 | -0.09 | |
| Normalized Basic EPS | -- | -0.02 | -0.03 | -0.03 | |
| EPS Diluted | -- | -2.83 | -2.84 | -0.09 | |
| Normalized Diluted EPS | -- | -0.02 | -0.03 | -0.03 | |
| Average Basic Shares Outstanding | -- | 752.94M | 687.68M | 884.71M | |
| Average Diluted Shares Outstanding | -- | 752.94M | 687.68M | 884.71M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |